P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

April 2007

Features

Editor’s Memo

Goodbye, Larry

P&T pays tribute to a long-time columnist and medical writer, Lawrence Prescott, PhD.
Sonja Sherritze

Commentary

Medication Reconciliation Meets Patient Safety: Irreconcilable Differences?

As with many well-intentioned feel-good initiatives, achieving the goals of the Medication Reconciliation Project will be a lot more difficult than dreaming them up.
Nancy Greengold, MD, MBA

Opinion

Abuse of Stimulant Medications for Attention-Deficit/Hyperactivity Disorder: A New Alternative

Stimulant drugs, considered a first-line therapy for ADHD, have a potential for misuse and abuse. A new agent may have less potential for these problems.
Frank A. López, MD

Cover Story

An Evaluation of Off-Label Use of Recombinant Activated Human Factor VII (NovoSeven): Patient Characteristics, Utilization Trends, and Outcomes from an Electronic Database of U.S. Academic Health Centers

As a therapy for bleeding, rFVIIa is often prescribed for off-label indications, and this trend is increasing. The authors suggest possible new prescribing guidelines.
Sandra Magnetti, MS, DrPH, Michael Oinonen, PharmD, MPH, and Karl A. Matuszewski, MS, PharmD

Meeting Highlights

American Society of Hematology: 48th Annual Meeting and Exposition

The author reviews therapies for multiple myeloma, chronic myeloid leukemia, paroxysmal nocturnal hemolysis, and B-cell chronic lymphocytic leukemia.
Walter Alexander

Pharmaceutical Approval Update

Marvin M. Goldenberg, PhD, RPh, MS

Departments

Editorial

HealthCast 2020

David Nash, MD, MBA, summarizes a series of reports on global trends for a sustainable health care system of the future in terms of health care spending, shared financial risks among private and public payers, and the continuing need for transparency in the quality and pricing of health care.
Marvin M. Goldenberg, PhD, RPh, MS

Medication Errors

Spectrum of Problems with Using Color

Matthew Grissinger, RPh, FASCP, discusses problems with color coding in pharmaceutical products.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Generic Biotechnology Drugs Could Win Congressional Approval; FDA Approval Would Be Trickier

Stephen Barlas predicts that it will be a lot easier for Congress to authorize the FDA to oversee the approval of generic biotech drugs than it will be for the FDA to implement the approval process.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

P&T presents the latest information from the FDA.

Drug Forecast

Rimonabant (Acomplia): The First Cannabinoid-1 Receptor Blocker for Obesity

The authors review rimonabant (Acomplia) for the treatment of obesity.
Carla A. Luque, PharmD, Megan J. Ehret, PharmD, and Jose A. Rey, PharmD, BCPP